Am I the only one reading it negatively?
PXS so far has failed everything they approached: NASH and Diabetic indications with BI, LOXL-2 dead in water after bragging deals for over 3 years.
Don't credit Bronchitol to the current management, as it was developed before 2015 by the previous team and brought to FDA/US by Chiesi.
Now without any real progress in past 3 years, their started with fresh attempt 5505 and even a scar/burn trail...any reasonable investors will naturally ask the question: why should we trust them?
Am I the only one reading it negatively?PXS so far has failed...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $59.04M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.2¢ | $39.11K | 895.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 752779 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |